Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Screeners that run automatically... and then email you the results! FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Theravance Bio Ord (TBPH)
Theravance Bio Ord (TBPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 665,138
  • Shares Outstanding, K 63,226
  • Annual Sales, $ 51,350 K
  • Annual Income, $ 872,130 K
  • 60-Month Beta 0.51
  • Price/Sales 12.73
  • Price/Cash Flow N/A
  • Price/Book 1.58
Trade TBPH with:

Options Overview Details

View History
  • Implied Volatility 38.69% ( +1.94%)
  • Historical Volatility 41.41%
  • IV Percentile 13%
  • IV Rank 12.77%
  • IV High 127.46% on 07/13/22
  • IV Low 25.69% on 09/20/22
  • Put/Call Vol Ratio 0.00
  • Today's Volume 2
  • Volume Avg (30-Day) 245
  • Put/Call OI Ratio 0.35
  • Today's Open Interest 3,856
  • Open Int (30-Day) 12,193

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/23
See More
  • Average Estimate -0.27
  • Number of Estimates 5
  • High Estimate -0.14
  • Low Estimate -0.32
  • Prior Year -0.24
  • Growth Rate Est. (year over year) -12.50%

Price Performance

See More
Period Period Low Period High Performance
1-Month
9.25 +16.65%
on 02/28/23
10.89 -0.92%
on 02/28/23
+0.23 (+2.18%)
since 02/27/23
3-Month
9.25 +16.65%
on 02/28/23
11.52 -6.34%
on 01/18/23
-0.24 (-2.18%)
since 12/27/22
52-Week
7.53 +43.29%
on 07/14/22
11.83 -8.79%
on 11/17/22
+1.08 (+11.12%)
since 03/25/22

Most Recent Stories

More News
Theravance Biopharma to Participate in an Upcoming Investor Conference

/PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH) will participate in the Respiratory/Infections Corporate Panel Discussion at the 43rd Annual TD Cowen...

TBPH : 10.79 (+2.57%)
Corcept's (CORT) Q4 Earnings and Revenues Miss Estimates

Corcept Therapeutics' (CORT) fourth-quarter earnings and revenues lag estimates.

MRK : 106.93 (+2.03%)
CORT : 21.64 (-0.60%)
CPRX : 16.44 (+1.99%)
TBPH : 10.79 (+2.57%)
Theravance's (TBPH) Q4 Earnings and Revenues Miss Estimates

Thervance's (TBPH) fourth-quarter loss wider than expected. Revenues decline year over year.

JNJ : 153.30 (+0.43%)
TBPH : 10.79 (+2.57%)
CRSP : 44.35 (+2.12%)
VTRS : 9.47 (+1.50%)
Theravance Biopharma (TBPH) Reports Q4 Loss, Lags Revenue Estimates

Theravance Bio (TBPH) delivered earnings and revenue surprises of -5% and 19.73%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

TBPH : 10.79 (+2.57%)
LYRA : 2.0800 (+6.67%)
Theravance Bio: Q4 Earnings Snapshot

Theravance Bio: Q4 Earnings Snapshot

TBPH : 10.79 (+2.57%)
Theravance Biopharma, Inc. Announces Strategic Actions and Reports Fourth Quarter / Full Year 2022 Financial Results and Business Update

Increases capital return program to $325 million from $250 million; as of 2/27/23, approximately $170 million remains in the program Discontinuing investments...

TBPH : 10.79 (+2.57%)
Irenic Sends Letter to Theravance Biopharma Regarding the Urgent Need for a Governance Overhaul, Capital Return and Strategic Review

Irenic Capital Management, LP, a top shareholder of Theravance Biopharma, Inc. (NASDAQ: TBPH), today released the below letter.

TBPH : 10.79 (+2.57%)
4 Drug, Biotech Stocks Poised to Beat Q4 Earnings Estimates

We look at a few drug/biotech companies, TBPH, FGEN, AUPH, CYTK, which are poised to beat on earnings in the fourth quarter.

CYTK : 34.53 (+3.51%)
TBPH : 10.79 (+2.57%)
FGEN : 18.71 (+3.09%)
AUPH : 10.82 (+4.95%)
Catalyst (CPRX) to Report Q4 Earnings: What's in the Cards?

Revenues of Catalyst Pharmaceuticals (CPRX) are expected to have been driven by the sales of its only marketed product, Firdapse, for treating LEMS, along with the drug's label expansion for the treatment...

CPRX : 16.44 (+1.99%)
TBPH : 10.79 (+2.57%)
ASRT : 6.00 (+2.39%)
EQRX : 1.8200 (+1.11%)
Ironwood Pharmaceuticals (IRWD) Misses Q4 Earnings and Revenue Estimates

Ironwood (IRWD) delivered earnings and revenue surprises of -3.57% and 3.13%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

IRWD : 10.82 (+1.22%)
TBPH : 10.79 (+2.57%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Theravance Biopharma is a biopharmaceutical company primarily focused on discovering, developing and commercializing respiratory medicines. The company was formed following the split of the erstwhile Theravance into two listed companies in June 2014 - Innoviva, Inc. (then Theravance, Inc.) and Theravance.'...

See More

Key Turning Points

3rd Resistance Point 11.33
2nd Resistance Point 11.10
1st Resistance Point 10.95
Last Price 10.79
1st Support Level 10.57
2nd Support Level 10.34
3rd Support Level 10.19

See More

52-Week High 11.83
Last Price 10.79
Fibonacci 61.8% 10.19
Fibonacci 50% 9.68
Fibonacci 38.2% 9.17
52-Week Low 7.53

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar